Pharma energized by promise of quicker drug approvals

05/9/2013 | Reuters

The pharmaceutical industry is invigorated by the promise of quicker regulatory decisions, more targeted treatments and a pickup in new drug approvals as the effect of a major wave of patent expiries subsides. "It's a very exciting time in terms of advances in science and technology," FDA Commissioner Dr. Margaret Hamburg said. Signs of renewed investor confidence can be seen in stock prices.

View Full Article in:


Published in Briefs: